Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts
Nutrients · 17.01.2023 · 15 (3) · 480
DOI: 10.3390/nu15030480 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nutrients, online erschienen am 17.01.2023. Verfasst von Marjolein van Driel und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Internal Medicine, Room Ee585c, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands. Hauptthemen laut MEDLINE: Vitamin D, Bone and Bones. Die Arbeit wurde bisher 85-mal zitiert (Crossref) und nennt 155 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Despite its rigid structure, the bone is a dynamic organ, and is highly regulated by endocrine factors. One of the major bone regulatory hormones is vitamin D. Its renal metabolite 1α,25-OH2D3 has both direct and indirect effects on the maintenance of bone structure in health and disease. In this review, we describe the underlying processes that are directed by bone-forming cells, the osteoblasts. During the bone formation process, osteoblasts undergo different stages which play a central role in the signaling pathways that are activated via the vitamin D receptor. Vitamin D is involved in directing the osteoblasts towards proliferation or apoptosis, regulates their differentiation to bone matrix producing cells, and controls the subsequent mineralization of the bone matrix. The stage of differentiation/mineralization in osteoblasts is important for the vitamin D effect on gene transcription and the cellular response, and many genes are uniquely regulated either before or during mineralization. Moreover, osteoblasts contain the complete machinery to metabolize active 1α,25-OH2D3 to ensure a direct local effect. The enzyme 1α-hydroxylase (CYP27B1) that synthesizes the active 1α,25-OH2D3 metabolite is functional in osteoblasts, as well as the enzyme 24-hydroxylase (CYP24A1) that degrades 1α,25-OH2D3. This shows that in the past 100 years of vitamin D research, 1α,25-OH2D3 has evolved from an endocrine regulator into an autocrine/paracrine regulator of osteoblasts and bone formation.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Internal Medicine, Room Ee585c, Erasmus MC, Dr. Molewaterplein 40, 3015 GD Rotterdam, The Netherlands.
ORCID-Profile: Johannes P T M van Leeuwen
Zitieren
APA
van Driel, M., & van Leeuwen, J. P. T. M. (2023). Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts. Nutrients, 15(3), 480. https://doi.org/10.3390/nu15030480
Vancouver
van Driel M, van Leeuwen JPTM. Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts. Nutrients. 2023;15(3):480. doi:10.3390/nu15030480
BibTeX
@article{vanDriel2023,
author = {van Driel, Marjolein and van Leeuwen, Johannes P T M},
title = {Vitamin D and Bone: A Story of Endocrine and Auto/Paracrine Action in Osteoblasts},
journal = {Nutrients},
year = {2023},
volume = {15},
number = {3},
pages = {480},
doi = {10.3390/nu15030480}
}
EUVIMED